


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.15%
-10.04%
+13.13%
TMDX
TransMedics Group In
$138.09
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
TMDX Price Performance
$128.2 (+7.71%)
$132.45 (+4.26%)
$116.73 (+18.30%)
$73.5 (+87.88%)
TMDX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
TMDX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TMDX Street Sentiment is extremely bullish and have positive views on the near-term outlook
TMDX has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
TMDX
TransMedics Group In
138.09
+3.20%
SPOT
Spotify
498.64
-0.71%
NVAX
Novavax
9.75
-1.66%
EHGO
Eshallgo Inc.
0.24
+2.17%
NBTX
Nanobiotix S.A. American
21.19
+5.63%
What is TMDX current stock price?
What are TMDX stock strengths?
What is TMDX Risk Level?
What is TMDX market cap and volume?
What is TMDX current Stock IQ?
Should I buy TMDX stock right now?
Is TMDX a Strong Buy right now?
What does a 'Strong Buy' rating mean for TMDX?
What does a 'Strong Sell' rating mean for TMDX?
What factors influence TMDX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.15%
-10.04%
+13.13%
TMDX
TransMedics Group In
Current Price
$138.09
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Recently Viewed
TMDX
TransMedics Group In
138.09
+3.20%
SPOT
Spotify
498.64
-0.71%
NVAX
Novavax
9.75
-1.66%
EHGO
Eshallgo Inc.
0.24
+2.17%
NBTX
Nanobiotix S.A. American
21.19
+5.63%

TMDX Price Performance
$128.2 (+7.71%)
$132.45 (+4.26%)
$116.73 (+18.30%)
$73.5 (+87.88%)
TMDX Analysts Opinion
TMDX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
TMDX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TMDX Street Sentiment is extremely bullish and have positive views on the near-term outlook
TMDX has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Dec 18, 2025
Reiterate
Buy
Canaccord Genuity
Dec 09, 2025
Reiterate
Buy
Needham
Dec 08, 2025
Reiterate
Buy
Oct 30, 2025
Reiterate
Overweight
Piper Sandler
Oct 30, 2025
Reiterate
Buy
Canaccord Genuity
TMDX Stock IQ
TMDX Latest Analysis
TransMedics stock falls after Bridge to Life wins FDA clearance for liver device.
Wed Jan 21, 2026
Reasons to Retain TransMedics Stock in Your Portfolio for Now. TMDX gains momentum as OCS technology a robust pipeline and strong Q3 results fuel growth though gross margin pressure tempers the outlook.
Wed Jan 14, 2026
TransMedics: Strong Growth And A Better Setup.
Tue Jan 13, 2026
TransMedics Group Inc. (TMDX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.
Tue Jan 13, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
TMDX Stock trends
TMDX Stock performance
TMDX Stock analysis
TMDX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.